Optogenetic stimulation of vagal nerves for enhanced glucose-stimulated insulin secretion and β cell proliferation

Yohei Kawana1, Junta Imai2, Yosuke M Morizawa3

  • 1Department of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.

PubMed

Insights

Optogenetic stimulation of the vagal nerve enhances insulin secretion and pancreatic beta cell proliferation. These novel methods offer potential new therapies for diabetes by precisely controlling nerve signals.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Biomedical Engineering

Background:

  • Diabetes mellitus is a metabolic disorder characterized by impaired insulin secretion and beta cell function.
  • The vagal nerve plays a crucial role in regulating insulin secretion and beta cell proliferation, but effective stimulation methods are lacking.
  • Optogenetics offers precise control over neural activity, presenting a potential solution for targeted vagal nerve stimulation.

Purpose of the Study:

  • To develop and evaluate optogenetic techniques for selective and prolonged vagal nerve stimulation.
  • To investigate the impact of vagal nerve stimulation on glucose-stimulated insulin secretion and pancreatic beta cell proliferation.
  • To assess the therapeutic potential of these optogenetic methods in a mouse model of diabetes.

Main Methods:

  • Developed two optogenetic strategies for vagal nerve stimulation in mice expressing channelrhodopsin-2.
  • Method 1: Subdiaphragmatic implantation of an optical fiber for blue-light photostimulation of cholinergic neurons.
  • Method 2: Intra-pancreatic duct delivery of lanthanide microparticles for near-infrared activation of vagal fibers.

Main Results:

  • Both optogenetic methods successfully enhanced glucose-stimulated insulin secretion.
  • Optogenetic stimulation promoted pancreatic beta cell proliferation.
  • The second method, utilizing near-infrared light, suppressed streptozotocin-induced hyperglycemia in mice.
  • Demonstrated that vagal nerve signals, particularly those innervating the pancreas, are sufficient to regulate insulin secretion and beta cell growth.

Conclusions:

  • Optogenetic stimulation of the vagal nerve is a viable strategy for enhancing insulin secretion and beta cell proliferation.
  • These findings highlight the therapeutic potential of vagal nerve modulation for diabetes treatment.
  • The developed optogenetic tools provide precise control for future research into neuro-endocrine regulation.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.4K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
332